Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model

By sjmartinez • October 16, 2023

Iannone V, Babu AF, Lok J, Gómez-Gallego C, D'Auria G, Vazquez-Uribe R, Vaaben TH, Bongers M, Mikkonen S, Vaittinen M, Tikkanen I, Kettunen M, Klåvus A, Sehgal R, Kaminska D, Pihlajamaki J, Hanhineva K, El-Nezami H, Alexander Sommer MO, Kolehmainen M. Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model. Mol Metab. 2023 Oct 13:101823. doi: 10.1016/j.molmet.2023.101823. Epub ahead of print. PMID: 37839774.

Tags: aldafermin, Cardiology/Epi, genetically modified E. coli Nissle 1917, Metabolic dysfunction-associated steatotic liver disease, non-alcoholic fatty liver disease, non-targeted metabolomics, omics integration, Publications, Transcriptomics

Central Adiposity and Inflammation Mediate the Association Between Ultraprocessed Food Intake and Cardiovascular Disease Risk

Haidar A, Flynn S, Rikhi R, Watson KE, Wood AC, Shapiro MD. Central Adiposity and Inflammation Mediate the Association Between Ultraprocessed Food Intake and Cardiovascular[...]

Temporal and Regional Trends in Cardiovascular Mortality Associated With Diabetes Mellitus: A Nationwide Analysis From 1999 to 2020 in the United States

Ahmed S, Ahmed S, Ahmad E, Ashraf H, Akram U, Ahmad S, Uwishema O, Hassan IN, Ullah I, Ata F, Cheema AH, Alraies C, Fonarow[...]

A Polypill Strategy to Close the Heart Failure Treatment Gap

Fonarow GC, McMurray JJV. A Polypill Strategy to Close the Heart Failure Treatment Gap. JAMA Cardiol. 2026 Sep 30. doi: 10.1001/jamacardio.2026.3727. Epub ahead of print.[...]